Bulletin 2009/06 - European Patent Office

(C07D) II.1(1)
Europäisches Patentblatt
European Patent Bulletin
Bulletin européen des brevets
Patente
Patents
Brevets (06/2009) 04.02.2009
(87) WO 2003/087062 2003/43 23.10.2003
(30) 05.04.2002 IN MU03272002
(54) • 4-(HETEROCYCLYL)-BENZENESULFOXI-
MIN VERBINDUNGEN ZUR BEHANDLUNG
ENTZÜNDLICHER ERKRANKUNGENEN
• 4-(HETEROCYCLYL)-BENZENESULFOXI-
MINE COMPOUNDS FOR THE TREATMENT
OF INFLAMMATION
• 4-(HETEROCYCLYL)-BENZENESULFOXI-
MINES, LEUR PROCEDE DE PREPARA-
TION, LES COMPOSITIONS
PHARMACEUTIQUES LES CONTENANT ET
LEUR UTILISATION POUR LE TRAITE-
MENT DE MALADIES INFLAMMATOIRES
(73) CADILA HEALTHCARE LIMITED, Zydus
Tower, Satellite Cross Roads, Ahmedebad
380 015, Gujarat, IN
(72) LOHRAY, Braj, Bhushan, Ahmedabad 380
015 Gujarat, IN
LOHRAY, Vidya, Bhushan, Ahmedabad 380
015 Gujarat, IN
JAIN, Mukul, R., Ahmedabad 380 015
Gujarat, IN
PATEL, Gautam, D., Ahmedabad 380 015
Gujarat, IN
PINGALI, Harikishore, Ahmedabad 380 015
Gujarat, IN
(74) Manaton, Ross Timothy, Bromhead Johnson
19 Buckingham Street, London WC2 6EF, GB
(51) C07D 231/56 (11) 1 542 976 B1
C07D 409/04 A61K 31/416
A61P 5/26 A61P 25/28
A61P 29/00 A61P 19/02
A61P 3/06
(25) En (26) En
(21) 03799289.8 (22) 24.09.2003
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HU IE IT LI LU MC NL PT RO SE SI SK
TR
AL LT LV MK
(43) 22.06.2005
(86) US 2003/030252 24.09.2003
(87) WO 2004/031159 2004/16 15.04.2004
(30) 25.09.2002 US 413931 P
(54) • SUBSTITUIERTE 4-(INDAZOL-3-YL)PHE-
NOLE ALS LIGANDEN DES OESTROGEN-
REZEPTORS UND DEREN VERWENDUNG
BEI DER BEHANDLUNG VON ENTZÜND-
LICHEN ERKRANKUNGEN
• SUBSTITUTED 4-(INDAZOL-3-YL)PHE-
NOLS AS ESTROGEN RECEPTOR (ER)
LIGANDS AND THEIR USE IN THE
TREATMENT OF INFLAMMATORY DIS-
EASES
• 4-(INDAZOL-3-YL)PHENOLS SUBSTITUES
COMME LIGANDS DU RECEPTEUR DES
OESTROGENES ET LEUR UTILISATION
DANS LE TRAITEMENT DE MALADIES
INFLAMMATOIRES
(73) Wyeth, Five Giralda Farms, Madison, New
Jersey 07940, US
(72) STEFFAN, Robert, John, Langhorne, PA
19047, US
MATELAN, Edward, Martin, Royersford, PA
19468, US
ASHWELL, Mark, Anthony, Carlisle, MA
01741, US
SOLVIBILE, William, Ronald, East Windsor,
NJ 08520, US
(74) Wileman, David Francis, Wyeth Pharmaceuticals,
Patent Department, Huntercombe
Lane South, Taplow, Maidenhead, Berkshire
SL6 OPH, GB
C07D 241/12 → (51) C07C 317/14
C07D 257/06 → (51) C07C 59/90
C07D 261/08 → (51) C07D 231/12
C07D 263/38 → (51) C07D 231/12
C07D 277/34 → (51) C07C 59/90
C07D 277/34 → (51) C07D 231/12
(51) C07D 285/10 (11) 1 551 818 B1
C07D 417/12 C07D 417/14
A61K 31/433 A61K 31/4436
(25) En (26) En
(21) 03781311.0 (22) 07.10.2003
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HU IE IT LI LU MC NL PT RO SE SI SK
TR
AL LT LV MK
(43) 13.07.2005
(86) US 2003/031707 07.10.2003
(87) WO 2004/033440 2004/17 22.04.2004
(30) 09.10.2002 US 417371 P
(54) • THIADIAZOLDIOXIDE UND THIADIAZOLO-
XIDE ALS CXC- UND CC-CHEMOKINRE-
ZEPTOR LIGANDEN
• THIADIAZOLEDIOXIDES AND THIADIAZO-
LEOXIDES AS CXC- AND CC-CHEMOKINE
RECEPTOR LIGANDS
• THIADIAZOLEDIOXYDES ET THIADIAZO-
LEOXIDES CONVENANT COMME LIGANDS
DES RECEPTEURS DES CXC- ET CC-
CHIMIOKINES
(73) Schering Corporation, 2000 Galloping Hill
Road, Kenilworth, NJ 07083-0530, US
Pharmacopeia, Inc., 3000 Eastpark Boulevard,
Cranbury, NJ 08512, US
(72) TAVERAS, Arthur, G., Denville, NJ 07834, US
CHAO, Jianhua, Pompton Lakes, NJ 07442,
US
BIJU, Purakkattle, J., Scotch Plains, NJ
07076, US
YU, Younong, New Jersey 08816, US
FINE, Jay, S., Bloomfield, NJ 07003, US
HIPKIN, William, Cranford, NJ 07016, US
AKI, Cynthia, J., Livingston, NJ 07039, US
MERRITT, J., Robert, Ewing, NJ 08618, US
LI, Ge, LuJiaZui, 200135 Shanghai, CN
BALDWIN, John, J., Gwynedd Valley, PA
19437, US
LAI, Gaifa, Monmouth Junction, NJ 08852,
US
WU, Minglang, Monmouth Junction, NJ
08852, US
HECKER, Evan, A., Austin, TX 78751, US
(74) UEXKÜLL & STOLBERG, Patentanwälte
Beselerstrasse 4, 22607 Hamburg, DE
C07D 307/46 → (51) C07D 231/12
C07D 401/04 → (51) C07D 231/12
C07D 401/06 → (51) C07D 213/79
C07D 401/08 → (51) C07D 213/79
C07D 401/12 → (51) C07D 213/79
C07D 405/12 → (51) C07D 213/79
C07D 409/04 → (51) C07D 231/56
C07D 409/12 → (51) C07D 213/79
C07D 413/06 → (51) C07D 213/79
C07D 413/08 → (51) C07D 213/79
C07D 413/12 → (51) C07D 213/79
C07D 417/06 → (51) C07D 213/79
C07D 417/08 → (51) C07D 213/79
C07D 417/12 → (51) C07D 213/79
C07D 417/12 → (51) C07D 285/10
C07D 417/14 → (51) C07D 285/10
C07D 471/02 → (51) C07C 317/14
C07D 513/00 → (51) A61K 31/54
C07D 513/02 → (51) A61K 31/54
C07D 513/04 → (51) A61K 31/54
(51) C07H 17/02 (11) 1 660 509 B1
A61K 31/7056 A61P 3/10
(25) De (26) De
(21) 04764316.8 (22) 20.08.2004
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB
GR HU IE IT LI LU MC NL PL PT RO SE SI SK
TR
(43) 31.05.2006
(86) EP 2004/009332 20.08.2004
(87) WO 2005/021566 2005/10 10.03.2005
(30) 26.08.2003 DE 10339549
18.12.2003 DE 10359960
(54) • GLUCOPYRANOSYLOXY-PYRAZOLE,
DIESE VERBINDUNGEN ENTHALTENDE
ARZNEIMITTEL, DEREN VERWENDUNG
UND VERFAHREN ZU IHRER HERSTEL-
LUNG
• GLUCOPYRANOSYLOXY- PYRAZOLES,
PHARMACEUTICAL COMPOSITIONS CON-
TAINING THESE COMPOUNDS, THE USE
THEREOF AND PROCESSES FOR THE
PREPARATION THEREOF
• PYRAZOLES GLUCOPYRANOSYLOXY,
MEDICAMENTS CONTENANT CES COM-
POSES, LEUR UTILISATION ET LEUR
PROCEDE DE PRODUCTION
(73) Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am
Rhein, DE
(84) AT BE BG CH CY CZ DK EE ES FI FR GB GR
HU IE IT LI LU MC NL PL PT RO SE SK TR SI
(73) Boehringer Ingelheim Pharma GmbH & Co.
KG, Binger Strasse 173, 55216 Ingelheim am
Rhein, DE
(84) DE
(72) HIMMELSBACH, Frank, 88441 MITTELBI-
BERACH, DE
EICKELMANN, Peter, 65191 WIESBADEN,
DE
THOMAS, Leo, 88400 BIBERACH, DE
BARSOUMIAN, Edward Leon, TOYONAKA,
Osaka 560-0005, JP
(74) Hammann, Heinz, et al, Boehringer Ingelheim
GmbH CD-Patents Binger Strasse 173,
55216 Ingelheim am Rhein, DE
C07K 14/435 → (51) C12N 15/861
(51) C07K 14/47 (11) 1 127 944 B1
C12N 9/12 C12N 15/09
G01N 33/564 G01N 33/15
G01N 33/577 A61K 45/00
C12Q 1/02 G01N 33/53
C12Q 1/48
(25) Ja (26) En
(21) 99949347.1 (22) 21.10.1999
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI
LU MC NL PT SE
(43) 29.08.2001
(86) JP 1999/005817 21.10.1999
(87) WO 2000/023610 2000/17 27.04.2000
230